Simponi 50 mg (Orifarm) inj. opl. s.c. voorgev. pen 0.5 ml
Active ingredient: Golimumab
View notice details →
News topic
Current shortage notices for the active ingredient Golimumab, structured by product, country and reporting period.
2 noticesActive ingredient: Golimumab
View notice details →Active ingredient: Golimumab
View notice details →